These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9649925)

  • 1. Alterations in collagen subtype III and IV protein in experimental venous bypass grafting.
    Fulton GJ; Channon KM; Davies MG; Annex BH; Hagen PO
    Coron Artery Dis; 1998; 9(4):191-7. PubMed ID: 9649925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
    Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
    J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of tissue factor protein expression in experimental venous bypass grafts.
    Channon KM; Fulton GJ; Davies MG; Peters KG; Ezekowitz MD; Hagen PO; Annex BH
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1313-9. PubMed ID: 9261261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
    J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
    Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
    J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low molecular weight heparin on intimal hyperplasia in vein grafts.
    Wilson NV; Salisbury JR; Kakkar VV
    Eur J Vasc Surg; 1994 Jan; 8(1):60-4. PubMed ID: 8307218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
    Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
    J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The temporal sequence of G-protein expression in intimal hyperplasia.
    Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
    J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
    Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
    J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Thompson MA; Ezekowitz MD; Hagen P; Annex BH
    J Vasc Surg; 2001 Feb; 33(2):400-7. PubMed ID: 11174796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
    Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
    Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts.
    Huynh TT; Davies MG; Trovato MJ; Svendsen E; Hagen PO
    J Vasc Surg; 1999 Feb; 29(2):334-44. PubMed ID: 9950991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril and experimental vein graft intimal hyperplasia.
    Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
    Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
    Davies MG; Huynh TT; Hagen PO
    J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.